First, we validated the

First, we validated the ABT-199 molecular weight silencing effect of KLF15-specific short-hairpin RNA (shRNA), which was expressed using the Invitrogen BLOCK-it miR RNAi vector that also contains an embedded EmGFP cassette, in Huh7 cells. As shown in Fig. 6A, four independent KLF15 miR RNAi constructs (Cons1-4) could each reduce the KLF15 mRNA level by approximately 60% at 48 hours after transfection. Next, we introduced the KLF15 RNAi construct 4 with pAAV-HBV1.2 into

the mouse liver using the hydrodynamic injection. Because the transfection efficiency of this injection procedure ranges from 10% to 40%, transfected (i.e., GFP-positive) and nontransfected (i.e., GFP-negative) hepatocytes were separated by cell sorting after liver perfusion. Similar to Huh7 cells, the KLF15 mRNA level in KLF15 RNAi construct-transfected hepatocytes was reduced by approximately 60% when it was compared with the nontransfected hepatocytes. Such a reduction was not observed if the KLF15 RNAi construct was replaced with the control RNAi construct (Fig. 6B). These results indicated that the KLF15 RNAi construct could also reduce the expression of KLF15 in mouse hepatocytes. To determine the effect of KLF15 knockdown on HBV gene expression, we performed immunofluorescence staining on mouse liver tissue sections.

In mice coinjected with the control RNAi construct and pAAV-HBV1.2 Nutlin-3a supplier (Fig. 6C), almost all the cells positive for GFP were also positive for HBcAg, indicating the successful cotransfection of the same hepatocytes Aspartate by the RNAi construct and the HBV genome. However, when the control RNAi construct was replaced by the KLF15 RNAi construct, the HBcAg signal in GFP-positive cells was greatly diminished. This immunofluorescence staining result was further confirmed by Western blot analysis of the core protein. As shown in Fig. 6D, the liver of mice injected with the KLF15 RNAi construct had a lower level of the core protein than the liver of mice injected with the control RNAi construct. These results indicated that the knockdown of KLF15 expression could result in the suppression of core protein expression.

After the codelivery of pAAV-HBV1.2 and RNAi constructs (KLF15 construct 4 or the control vector) into the mouse liver through hydrodynamic injection, we monitored the level of HBsAg in the serum of injected mice. pAAV-HBV1.2 contains the 1.2-mer HBV genome in an AAV vector. This construct was previously shown to lead to a high replication level of HBV in the mouse liver.33 Our results indicated that mice with a KLF15 knockdown had consistently lower levels of HBsAg than control mice (Fig. 7A and B). This reduction of the HBsAg level was more dramatic with 50 than with 30 μg of KLF15 RNAi construct (data not shown), indicating a dose-dependent effect of the KLF15 RNAi construct on HBsAg expression in mice.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>